Rosetta Genomics Ltd (NASDAQ:ROSG)

3.72
Delayed Data
As of Apr 24
 +0.06 / +1.64%
Today’s Change
2.07
Today|||52-Week Range
5.55
+64.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-10.1M-10.5M-12.9M-14.5M
 
 
 
 
 
Depreciation454.0K274.0K298.0K299.0K
 
 
 
 
 
Total Other Cash Flow465.0K2.5M1.2M943.0K
 
 
 
 
 
Funds From Operations-9.2M-7.7M-11.4M-13.3M
 
 
 
 
 
Funds From/For Other Operating Expenses2.1M906.0K-795.0K318.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-11.3M-8.6M-10.6M-13.6M
 
 
 
 
 
 
InvestingIncrease In Investments-37.0K---7.5M--
 
 
 
Decrease In Investments226.0K3.0K0.0017.0K
 
 
 
 
Capital Expenditures-11.0K-270.0K-626.0K-247.0K
 
 
 
 
 
Fixed Asset Disposal982.0K60.0K--0.00
 
 
 
Net Assets From Acquisitions 0.00-18.0K----
 
 
Other Investing - Uses-3.7M0.000.00-28.0K
 
 
 
Other Investing - Sources0.000.0010.0K0.00
 
 
Net Cash Flow Investing-2.5M-225.0K-8.2M-258.0K
 
 
 
 
 
 
FinancingShort Term Borrowings-70.0K-28.0K0.000.00
 
 
 
Long Term Borrowings0.001.8M0.000.00
 
 
Long Term Debt Reduction0.00-1.5M0.000.00
 
 
Net Proceeds Stock Sale9.6M38.7M4.7M5.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing2.2M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing11.8M38.9M4.7M5.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-2.0M30.1M-14.0M-8.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account